Seizures and the natural history of World Health Organization Grade II gliomas: a review (Q37838691)

24 August 2017

1 reference

title

Seizures and the natural history of World Health Organization Grade II gliomas: a review (English)

1 reference

World Health Organization

24 August 2017

main subject

0 references

2

Hugues Duffau

0 references

author name string

Anja Smits

series ordinal

1

1 reference

24 August 2017

language of work or name

English

0 references

publication date

1 May 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

68

1 reference

24 August 2017

issue

5

1 reference

24 August 2017

page(s)

1326-1333

1 reference

The 2007 WHO classification of tumours of the central nervous system

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Epidemiology and etiology of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Epilepsy in low‐grade gliomas: The impact on cognitive function and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Continuous growth of mean tumor diameter in a subset of grade II gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Volumes and growth rates of untreated adult low-grade gliomas indicate risk of early malignant transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Low-grade oligodendroglioma: an indolent but incurable disease? Clinical article

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Seizure characteristics and control following resection in 332 patients with low-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Brain tumors and epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

The pathogenesis of tumour associated epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Brain tumor and seizures: pathophysiology and its implications for treatment revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Epilepsy in cerebral glioma: timing of appearance and histological correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Preferential brain locations of low-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Factors influencing seizures in adult patients with supratentorial astrocytic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Epileptic seizures and survival in early disease of grade 2 gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Adult supratentorial low-grade glioma: long-term experience at a single institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Prognostic factors for survival in adult patients with cerebral low-grade glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

A personal consecutive series of surgically treated 51 cases of insular WHO Grade II glioma: advances and limitations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Prognostic factors in well-differentiated cerebral astrocytomas in the adult.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Supratentorial World Health Organization Grade 2 astrocytomas and oligoastrocytomas. A new pattern of prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Low-grade gliomas of chronic epilepsy: a distinct clinical and pathological entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Preoperative history and postoperative survival of supratentorial low-grade astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Current concepts in the evaluation and management of WHO grade II gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Evidence for a clinically distinct new subtype of grade II astrocytomas in patients with long-term epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

An isomorphic subtype of long-term epilepsy-associated astrocytomas associated with benign prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Patients with refractory seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Outcome of adult patients with temporal lobe tumours and medically refractory focal epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Temporal lobe tumoral epilepsy: characteristics and predictors of surgical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Surgery of low-grade gliomas: towards a 'functional neurooncology'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Medically intractable epilepsy from insular low-grade gliomas: improvement after an extended lesionectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Effect of cranial irradiation on seizure frequency in adults with low-grade astrocytoma and medically intractable epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Epilepsy and insular Grade II gliomas: an interdisciplinary point of view from a retrospective monocentric series of 46 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Re-operation is a safe and effective therapeutic strategy in recurrent WHO grade II gliomas within eloquent areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Epileptic seizures during follow-up of patients treated for primary brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Tumor-associated epilepsy and glioma: are there common genetic pathways?

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Surgical pathology of chronic epileptic seizure disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Gene expression profile analysis of epilepsy-associated gangliogliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Mirror focus: function of seizure frequency and influence on outcome after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

Cognitive deficits in adult patients with brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2FNEU.0B013E31820C3419

10.1227/NEU.0B013E31820C3419

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference